HAE

Haemonetics (HAE)

Haemonetics Corp

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:HAE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	06 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/30	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/30	06 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/30	06 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/30	06 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/30	06 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/30	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:HAE	Haemonetics Corp
2024/05/30	00 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/29	23 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/29	05 : 34	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:HAE	Haemonetics Corp
2024/05/23	19 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:HAE	Haemonetics Corp
2024/05/23	19 : 00	PR Newswire (US)	Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes	NYSE:HAE	Haemonetics Corp
2024/05/22	19 : 37	IH Market News	Nvidia Profits Set to Challenge Historic High Market; GE Aerospace Announces New Hires, and More News	NYSE:HAE	Haemonetics Corp
2024/05/22	07 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/22	07 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/22	06 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/22	06 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/22	06 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/22	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/22	06 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/22	06 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/22	06 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/22	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:HAE	Haemonetics Corp
2024/05/22	05 : 05	PR Newswire (US)	Haemonetics Announces Proposed Convertible Senior Notes Offering	NYSE:HAE	Haemonetics Corp
2024/05/21	00 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/21	00 : 13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/20	23 : 45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/20	19 : 16	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NYSE:HAE	Haemonetics Corp
2024/05/18	06 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	06 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp